Cargando…
EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802714/ https://www.ncbi.nlm.nih.gov/pubmed/29358618 http://dx.doi.org/10.1038/s41408-017-0045-4 |
| _version_ | 1783298571918901248 |
|---|---|
| author | Patnaik, Mrinal M. Vallapureddy, Rangit Lasho, Terra L. Hoversten, Katherine P. Finke, Christy M. Ketterling, Rhett Hanson, Curtis Gangat, Naseema Tefferi, Ayalew |
| author_facet | Patnaik, Mrinal M. Vallapureddy, Rangit Lasho, Terra L. Hoversten, Katherine P. Finke, Christy M. Ketterling, Rhett Hanson, Curtis Gangat, Naseema Tefferi, Ayalew |
| author_sort | Patnaik, Mrinal M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5802714 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58027142018-02-08 EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental Patnaik, Mrinal M. Vallapureddy, Rangit Lasho, Terra L. Hoversten, Katherine P. Finke, Christy M. Ketterling, Rhett Hanson, Curtis Gangat, Naseema Tefferi, Ayalew Blood Cancer J Correspondence Nature Publishing Group UK 2018-01-22 /pmc/articles/PMC5802714/ /pubmed/29358618 http://dx.doi.org/10.1038/s41408-017-0045-4 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Patnaik, Mrinal M. Vallapureddy, Rangit Lasho, Terra L. Hoversten, Katherine P. Finke, Christy M. Ketterling, Rhett Hanson, Curtis Gangat, Naseema Tefferi, Ayalew EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental |
| title | EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental |
| title_full | EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental |
| title_fullStr | EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental |
| title_full_unstemmed | EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental |
| title_short | EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental |
| title_sort | ezh2 mutations in chronic myelomonocytic leukemia cluster with asxl1 mutations and their co-occurrence is prognostically detrimental |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802714/ https://www.ncbi.nlm.nih.gov/pubmed/29358618 http://dx.doi.org/10.1038/s41408-017-0045-4 |
| work_keys_str_mv | AT patnaikmrinalm ezh2mutationsinchronicmyelomonocyticleukemiaclusterwithasxl1mutationsandtheircooccurrenceisprognosticallydetrimental AT vallapureddyrangit ezh2mutationsinchronicmyelomonocyticleukemiaclusterwithasxl1mutationsandtheircooccurrenceisprognosticallydetrimental AT lashoterral ezh2mutationsinchronicmyelomonocyticleukemiaclusterwithasxl1mutationsandtheircooccurrenceisprognosticallydetrimental AT hoverstenkatherinep ezh2mutationsinchronicmyelomonocyticleukemiaclusterwithasxl1mutationsandtheircooccurrenceisprognosticallydetrimental AT finkechristym ezh2mutationsinchronicmyelomonocyticleukemiaclusterwithasxl1mutationsandtheircooccurrenceisprognosticallydetrimental AT ketterlingrhett ezh2mutationsinchronicmyelomonocyticleukemiaclusterwithasxl1mutationsandtheircooccurrenceisprognosticallydetrimental AT hansoncurtis ezh2mutationsinchronicmyelomonocyticleukemiaclusterwithasxl1mutationsandtheircooccurrenceisprognosticallydetrimental AT gangatnaseema ezh2mutationsinchronicmyelomonocyticleukemiaclusterwithasxl1mutationsandtheircooccurrenceisprognosticallydetrimental AT tefferiayalew ezh2mutationsinchronicmyelomonocyticleukemiaclusterwithasxl1mutationsandtheircooccurrenceisprognosticallydetrimental |